These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8160198)

  • 1. An impurity present in some samples of SIN-1 oxidizes it to nitric oxide in anaerobic solutions.
    Wang Y; Rochelle LG; Kruszyna H; Kruszyna R; Smith RP; Wilcox DE
    Toxicology; 1994 Mar; 88(1-3):165-76. PubMed ID: 8160198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies of interactions of NO. donor drugs with superoxide and hydroxyl radicals.
    Dalloz F; Maupoil V; Lecour S; Briot F; Rochette L
    Mol Cell Biochem; 1997 Dec; 177(1-2):193-200. PubMed ID: 9450662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoactivation of the nitric oxide donor SIN-1.
    Ullrich T; Oberle S; Abate A; Schröder H
    FEBS Lett; 1997 Apr; 406(1-2):66-8. PubMed ID: 9109387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli.
    Brunelli L; Crow JP; Beckman JS
    Arch Biochem Biophys; 1995 Jan; 316(1):327-34. PubMed ID: 7840633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen modulation of guanylate cyclase-mediated retinal pericyte relaxations with 3-morpholino-sydnonimine and atrial natriuretic peptide.
    Haefliger IO; Anderson DR
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1563-8. PubMed ID: 9224284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-line detection of nitric oxide formation in liquid aqueous phase by electron paramagnetic resonance spectroscopy.
    Mordvintcev P; Mülsch A; Busse R; Vanin A
    Anal Biochem; 1991 Nov; 199(1):142-6. PubMed ID: 1666941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen and oxidation promote the release of nitric oxide from sydnonimines.
    Bohn H; Schönafinger K
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S6-12. PubMed ID: 2484701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Morpholino-sydnonimine-induced suppression of human neutrophil degranulation is not mediated by cyclic GMP, nitric oxide or peroxynitrite: inhibition of the increase in intracellular free calcium concentration by N-morpholino-iminoacetonitrile, a metabolite of 3-morpholino-sydnonimine.
    Kankaanranta H; Knowles RG; Vuorinen P; Kosonen O; Holm P; Moilanen E
    Mol Pharmacol; 1997 May; 51(5):882-8. PubMed ID: 9145927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of soluble guanylyl cyclase by the nitrovasodilator 3-morpholinosydnonimine involves formation of S-nitrosoglutathione.
    Schrammel A; Pfeiffer S; Schmidt K; Koesling D; Mayer B
    Mol Pharmacol; 1998 Jul; 54(1):207-12. PubMed ID: 9658207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nitric oxide donor SIN-1 protects endothelial cells from tumor necrosis factor-alpha-mediated cytotoxicity: possible role for cyclic GMP and heme oxygenase.
    Polte T; Oberle S; Schröder H
    J Mol Cell Cardiol; 1997 Dec; 29(12):3305-10. PubMed ID: 9441836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine.
    Holm P; Kankaanranta H; Metsä-Ketelä T; Moilanen E
    Eur J Pharmacol; 1998 Apr; 346(1):97-102. PubMed ID: 9617758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors.
    Singh RJ; Hogg N; Joseph J; Konorev E; Kalyanaraman B
    Arch Biochem Biophys; 1999 Jan; 361(2):331-9. PubMed ID: 9882464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molsidomine inhibits the chemoattractant-induced respiratory burst in human neutrophils via a no-independent mechanism.
    Ervens J; Seifert R
    Biochem Pharmacol; 1992 Aug; 44(4):637-44. PubMed ID: 1324680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type-dependent release of nitric oxide and/or reactive nitrogenoxide species from intracellular SIN-1: effects on cellular NAD(P)H.
    Swintek AU; Christoph S; Petrat F; de Groot H; Kirsch M
    Biol Chem; 2004 Jul; 385(7):639-48. PubMed ID: 15318813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the nitric oxide donors molsidomine and SIN-I on human polymorphonuclear leucocyte function in vitro and ex vivo.
    Darius H; Grodzinska L; Meyer J
    Eur J Clin Pharmacol; 1992; 43(6):629-33. PubMed ID: 1337322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GEA 3162 decomposes to co-generate nitric oxide and superoxide and induces apoptosis in human neutrophils via a peroxynitrite-dependent mechanism.
    Taylor EL; Rossi AG; Shaw CA; Dal Rio FP; Haslett C; Megson IL
    Br J Pharmacol; 2004 Sep; 143(1):179-85. PubMed ID: 15289284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular aspects underlying the vasodilator action of molsidomine.
    Noack E; Feelisch M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S1-5. PubMed ID: 2484685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthine oxidase converts nitric oxide to nitroxyl that inactivates the enzyme.
    Saleem M; Ohshima H
    Biochem Biophys Res Commun; 2004 Mar; 315(2):455-62. PubMed ID: 14766230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-arginine and SIN-1 on sleep and waking in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Life Sci; 2004 Sep; 75(17):2027-34. PubMed ID: 15312747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery.
    Govantes C; Rodríguez-Martínez MA; Marín J
    Methods Find Exp Clin Pharmacol; 1996; 18(6):387-95. PubMed ID: 8892268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.